BridgeMD
Intrathecal MRI Contrast for Assessment of CSF Transport
EU CTIS ID: 2024-519936-18-00
What this study is testing
Individualized assessment of CSF flow in CSF spaces and CNS Individualized assessment of CSF clearance
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Individuals with cerebral symptoms (including cognitive impairment and fatigue).
- Individuals with imaging evidence of neurological disease (CSF disorders, hydrocephalus, neoplasia in central nervous system).
- Individuals who receive medical treatment intended to treat the CNS (patients receiving intrathecal chemotherapeutic drugs to prevent tumor spread).
You likely can't join if
- Contrast allergy
- Renal failure
- < 18 years of age or >80 years of age
- Pregnant women
- Women who are breastfeeding
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.